LEVODOPA
Introduction to Levodopa (L-dopa) Levodopa, chemically known as L-3,4-dihydroxyphenylalanine, or more commonly referred to as L-dopa, represents the most critical therapeutic agent in the management of Parkinson’s disease (PD) and related movement disorders characterized by dopamine depletion. PD is pathologically defined by the degeneration of dopaminergic neurons in the substantia nigra, leading to a profound […]